Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
FDA Approval and Regulation of Pharmaceuticals, 1983-2018
2020220 citationsJonathan J. Darrow, Aaron S. Kesselheim et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Jonathan J. Darrow
Since
Specialization
Citations
This map shows the geographic impact of Jonathan J. Darrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Darrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Darrow more than expected).
Fields of papers citing papers by Jonathan J. Darrow
This network shows the impact of papers produced by Jonathan J. Darrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Darrow. The network helps show where Jonathan J. Darrow may publish in the future.
Co-authorship network of co-authors of Jonathan J. Darrow
This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan J. Darrow.
A scholar is included among the top collaborators of Jonathan J. Darrow based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Jonathan J. Darrow. Jonathan J. Darrow is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Darrow, Jonathan J.. (2018). Explaining the absence of surgical procedure regulation.. PubMed. 27(1). 189–206.8 indexed citations
8.
Kesselheim, Aaron S. & Jonathan J. Darrow. (2015). Hatch-Waxman Turns 30: Do We Need a Re-Designed Approach for the Modern Era?. PubMed. 15(2). 293–347.13 indexed citations
9.
Darrow, Jonathan J.. (2014). Crowdsourcing Clinical Trials. Minnesota law review.2 indexed citations
10.
Darrow, Jonathan J.. (2013). Pharmaceutical Efficacy: The Illusory Legal Standard. Washington and Lee law review. 70(4). 2073.9 indexed citations
11.
Darrow, Jonathan J.. (2011). Essential Medicines: Why International Price Discrimination May Increasingly Be the Wrong Solution to a Global Drug Problem. SSRN Electronic Journal.1 indexed citations
12.
Darrow, Jonathan J.. (2009). The Neglected Dimension of Patent Law's PHOSITA Standard. SSRN Electronic Journal. 23(1). 227.3 indexed citations
13.
Darrow, Jonathan J., et al.. (2008). The Search Engine Advertising Market: Lucrative Space or Trademark Liability?. SSRN Electronic Journal.1 indexed citations
14.
O'Brien, Christine Neylon & Jonathan J. Darrow. (2007). ADVERSE EMPLOYMENT CONSEQUENCES TRIGGERED BY CRIMINAL CONVICTIONS: RECENT CASES INTERPRET STATE STATUTES PROHIBITING DISCRIMINATION. SSRN Electronic Journal. 42(4). 991–1028.3 indexed citations
15.
Darrow, Jonathan J., et al.. (2007). 'Do You Really Need My Social Security Number?' Data Collection Practices in the Digital Age. SSRN Electronic Journal. 10(1). 1.1 indexed citations
16.
Darrow, Jonathan J., et al.. (2007). Social Networking Web Sites and the DMCA: A Safe-Harbor from Copyright Infringement Liability or the Perfect Storm?. SSRN Electronic Journal. 6(1). 1.2 indexed citations
17.
Darrow, Jonathan J.. (2006). The Patentability of Enantiomers: Implications for the Pharmaceutical Industry. SSRN Electronic Journal.6 indexed citations
18.
Darrow, Jonathan J., et al.. (2006). Employment Termination for Employee Blogging: Number One Tech Trend for 2005 and Beyond, or a Recipe for Getting Dooced?. SSRN Electronic Journal.3 indexed citations
19.
Darrow, Jonathan J., et al.. (2006). Who Owns a Decedent’s E-Mails: Inheritable Probate Assets or Property of the Network?. SSRN Electronic Journal.3 indexed citations
20.
O'Brien, Christine Neylon & Jonathan J. Darrow. (2004). The Question Remains After Raytheon Co. v. Hernandez: Whether No-Rehire Rules Disparately Impact Alcoholics and Former Drug Abusers. University of Pennsylvania journal of business law. 7(1). 157–172.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.